Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker

29 Apr 2025

Abstract excerpt

SLC16A3, belonging to the SLC16 gene family, is involved in the transportation of monocarboxylate. SLC16A family members play important roles in tumorigenesis, nonetheless, the specific involvement of SLC16A3 in tumor prognosis and diagnosis in human cancers remains unelucidated. This study dealt with the exploration of SLC16A3 expression in human pan-cancer and its significance regarding disease prognosis. For...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40301866
DOI: 10.1186/s12935-025-03791-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarkerPMID 40301866Read ↗

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformaticsSemantic proximity Read ↗

Validating S100A16 as a prognostic and immunological biomarker in pan-cancer and lung adenocarcinoma through integrated Single-cell Sequencing AnalysisSemantic proximity Read ↗

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer AnalysisSemantic proximity Read ↗

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma.Semantic proximity Read ↗

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.Semantic proximity Read ↗

Prognostic and immunological analysis of METTL16 in pan-cancerSemantic proximity Read ↗

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic TargetsSemantic proximity Read ↗

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive Pan-cancer Analysis of Cuproptosis-related Gene SLC31A1 as a Potential Biomarker for Cancer Survival and ImmunotherapySemantic proximity Read ↗

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-CancerSemantic proximity Read ↗

SLC17A9 Is a Novel Prognostic Biomarker Correlated With Immune Infiltrates in Human Lung Adenocarcinoma and Lung Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.